International boom: Yiling Pharmaceutical sees overseas revenue soar amid COVID-19 interest in Lianhua Qingwen botanical
International boom: Yiling Pharmaceutical sees overseas revenue soar amid COVID-19 interest in Lianhua Qingwen botanical Yiling Pharmaceutical, the company behind TCM/dietary supplement product Lianhua Qingwen, said revenue from its overseas market was up 918.37 per cent in FY2020, after the product was officially recognised by the China authorities as a COVID-19 standard therapy for mild symptoms such as fever and cough. Yiling Pharmaceutical’s growth in the overseas markets last year started from a small base of RMB$29m (US$4.56m) in FY2019. This grew to RMB$30...
Source: foodnavigator-asia.com